Posted inGenetics
Serotonin Receptor Structural Insights Open Path for Psychiatric Drugs
Activation of the serotonin receptor, 5-HT1A, has been shown to regulate mood and cognition. The receptor is the primary target…
Posted inGenetics
Asahi Kasei Life Science Plans New Spinning Plant for Its Planova Virus Removal Filters
Asahi Kasei Life Science plans to construct a new spinning plant for its Planova™ virus removal filters in Nobeoka City,…
Posted inGenetics
Psychedelics and Non-Hallucinogenic Analogs Share Neuroplasticity Pathway
Psychedelics—frequently recognized as substances such as LSD, psilocybin, and DMT—not only alter perception, mood, and cognition, but they often cause…
Posted inGenetics
Melanoma Cells in Mice Steered by Protein’s Unexpected Function
Researchers headed by a team at the The Barcelona Institute of Science and Technology (BIST) Centre for Genomic Regulation (CRG)…
Posted inBiotechnology
Tree Scarcity Hits African Informal City Settlements
Urban trees, often overlooked in the sprawling landscapes of African cities, represent much more than aesthetic adornments—they are vital components…
Posted inMedical Technology
Synchron links brain-computer interface to iPad through new Apple protocol
The brain-computer interface developer Synchron has shown that its minimally invasive device can help connect a patient with an iPad,…
Posted inBiotechnology
Senate committee opposes Trump’s NIH cuts, proposes $400M budget increase
A Senate committee has rejected President Donald Trump’s efforts to gouge funding for the National Institutes of Health (NIH), instead…
Posted inBiotechnology
Microplastics Found in Human Feces: Dietary Links Explored
In recent years, the ubiquity of microplastics in the environment has sparked growing concern among scientists and the public alike.…
Posted inBiotechnology
Prognostic Nutrition Index Predicts Liver Cancer Outcomes
In the ongoing battle against advanced hepatocellular carcinoma (HCC), a formidable liver cancer with high mortality rates, recent research has…
Posted inBiotechnology
Praxis links epilepsy drug to fall in seizures but sees 23% dropout rate
Praxis Precision Medicines has reported a 56.3% median reduction in seizure frequency from baseline in a midphase trial, encouraging the biotech…